The Startup of atDose
atDose was Founded on September 1, 2017 in Yokohama City, Kanagawa, Japan. Here's our logo at the time of our founding.
2017.9.1The Startup of atDose
Selected for SV members of Sido-2017
The CEO of atDose was selected as one of the 20 members of "Sido Next Innovator 2017" sponsored by the Ministry of Economy, Trade and Industry in Silicon Valley.
2018.1.22-2.4Selected for SV members of Sido-2017
Established the Laboratory at KBIC
Just one year after the company's launch, we set up a development base at the KBIC incubation facility in Kawasaki City.
2018.9.1Established the Laboratory at KBIC
Granted to NEDO NEP
CEO was granted to the "Research and Development Venture Support Project" by NEDO. NEDO is a national research and development agency that creates innovation by promoting technological development necessary for realization of a sustainable society.
2019.1.18Granted to NEDO NEP
Granted to KISTEC Research Proposal
The project has been selected for the "Research to Promote Industry-Academia-Government Collaboration" by the Kanagawa Institute of Science and Technology (KISTEC), a local independent administrative agency.
2019.6.12Granted to KISTEC Research Proposal
Selected for the ”The Springboard™ Program in Yokohama"
atDose has been selected as one of the four companies to be supported by the City of Yokohama's "The Springboard™ Program in Yokohama".
2019.7.4Selected for the ”The Springboard™ Program in Yokohama"
Selected for the Yokohama Acceleration Program
We were selected as one of eight companies in the Yokohama Acceleration Program, which supports the growth and development of venture businesses.
2019.7.25Selected for the Yokohama Acceleration Program
Company Award in TECH PLANTER
atDose was selected as one of the 12 finalist teams for the TECH PLANTER Biotech Grand Prix and received the Corporate Award "Mitsui Chemicals Award" at the final round.
2019.9.21Company Award in TECH PLANTER
The three companies start development for animal experiments
atDose Co., Ltd. , Phenovance Research & Technology, LLC and Teslasheet Inc. have signed a joint research agreement starting October 10, 2019.
2019.10.10The three companies start development for animal experiments
Selected YOXO Accelerator Program
atDose was selected as one of the 12 companies in the YOXO Accelerator Program of Yokohama City.
2019.12.26Selected YOXO Accelerator Program
Audience Award at Yokohama Business Grand Prix
At the Yokohama Business Grand Prix, held in Yokohama Minato Mirai, we received the Audience Award, which was decided by the audience's vote.
2020.2.22Audience Award at Yokohama Business Grand Prix
Broadcast on the TV show "Change the World"
atDose and our mobile drip device were featured on TV Tokyo and BS Tele-to "Change the World - Vision to Build the Future".
2020.3.29Broadcast on the TV show "Change the World"
Medical device manufacturing and marketing license
We obtained a license for the manufacture and sale of medical devices from Kanagawa Prefecture. Type of License: Class 1 Medical Device Marketing Authorization (All three medical device classifications can be handled) MAH No. 14B1X10026
2020.7.22Medical device manufacturing and marketing license
Distributed in three products: atDose Core, Mobile, and Multi
We have begun development of the atDose Multi, a miniaturized syringe pump used for intravenous (IV) medication. We will continue to develop three products: Core, Mobile, and Multi.
2020.8.6Distributed in three products: atDose Core, Mobile, and Multi
Raised 55.5 million yen
DEFTA Healthcare Technologies, L.P. (based in the U.S., Israel, Japan, Hong Kong, etc. / GP: DEFTA Capital, Inc. etc.; hereinafter referred to as "DHCT") and private investors raised 55.5 million yen through a private placement of new shares.
2020.8.31Raised 55.5 million yen
Start development of beauty equipment with Think-Lands
atDose and Think-Land will enter into a joint research agreement from September 2, 2020, to solve the challenges of the beauty industry.
2020.9.2Start development of beauty equipment with Think-Lands
Logo and website update
The logo was redesigned and the website was updated.
2020.10.28Logo and website update
Raised 40 million yen
DEFTA Healthcare Technologies, L.P. (based in the U.S., Israel, Japan, Hong Kong, etc. / GP: DEFTA Capital, Inc. etc.; hereinafter referred to as "DHCT") raised 40 million yen through a private placement of new shares.
2021.8.31Raised 40 million yen
Selected by JETRO Partners with Top Accelerators for Startup City Acceleration Program
JETRO will host an online acceleration program in partnership with the Cabinet Office of Japan from October 2021 to March 2022. In this program, JETRO will collaborate with 6 major accelerators to cultivate the growth of Japanese startup ecosystems. We have been selected as one of the 10 companies for the Bio/Healthcare Course by CIC.
2021.11.04Selected by JETRO Partners with Top Accelerators for Startup City Acceleration Program
Awarded the Kanagawa Prefecture Governor's Prize at the Kanagawa Business Audition
We received the Kanagawa Prefecture Governor's Award at the final judging of the Kanagawa Business Audition 2022, a business contest having a long history with 26 years.
2022.1.25Awarded the Kanagawa Prefecture Governor's Prize at the Kanagawa Business Audition
